Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein

Molecular Cell

Volumn 3, Issue 2, 1999, Pages 195-205

  Ross, John F ^a   Liu, Xuan ^b   Dynlacht, Brian David ^a  

^a HARVARD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; ELONGATION FACTOR 2; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL CYCLE; COMPLEX FORMATION; DNA FLANKING REGION; DNA FOOTPRINTING; GENE REPRESSION; HELA CELL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

GALLUS GALLUS;

EID: 0033083003     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80310-X     Document Type: Article

References (62)

1. Adnane, J., Shao, Z., and Robbins, P.D. (1995). The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J. Biol. Chem. 270, 8837-8843.
2. Brehm, A., Miska, E.A., McCance, D.J., Reid, J.L., Bannister, A.J., and Kouzarides, T. (1998). Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597-601.
3. Bremner, R., Cohen, B.L., Sopta, M., Hamel, P.A., Ingles, C.J., Gallie, B.L., and Phillips, R.A. (1995). Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol. Cell. Biol. 15, 3256-3265.
4. Buchkovich, K., Duffy, L.A., and Harlow, E. (1989). The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58, 1097-1105.
5. Buratowski, S., Hahn, S., Guarente, L., and Sharp, P.A. (1989). Five intermediate complexes in transcription initiation by RNA polymerase II. Cell 56, 549-561.
6. ∥60 of Drosophila. Genes Dev. 11, 3020-3031.
7. Chen, P.-L., Scully, P., Shew, J.-Y., Wang, J.Y.J., and Lee, W.-H. (1989). Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58, 1193-1198.
8. Chi, T., and Carey, M. (1996). Assembly of the isomerized TFIIA-TFIID-TATA ternary complex is necessary and sufficient for gene activation. Genes Dev. 10, 2540-2550.
9. Cress, W.D., and Nevins, J.R. (1996). A role for a bent DNA structure in E2F-mediated transcription activation. Mol. Cell. Biol. 16, 2119-2127.
10. DeCaprio, J.A., Ludlow, J.W., Lynch, D., Furukawa, Y., Griffin, J., Piwnica-Worms, H., Huang, C.-M., and Livingston, D.M. (1989). The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58, 1085-1095.
11. DeGregori, J., Kowalik, T., and Nevins, J.R. (1995). Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15, 4215-4224.
12. Dynlacht, B.D. (1997). Regulation of transcription by proteins that control the cell cycle. Nature 389, 149-152.
13. Dynlacht, B.D., Flores, O., Lees, J.A., and Harlow, E. (1994). Differential regulation of E2F trans-activation by cyclin-cdk2 complexes. Genes Dev. 8, 1772-1786.
14. Dynlacht, B.D., Moberg, K., Lees, J.A., Harlow, E., and Zhu, L. (1997). Specific regulation of E2F family members by cyclin-dependent kinases. Mol. Cell. Biol. 17, 3867-3875.
15. Dyson, N. (1998). The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262.
16. Fattaey, A.R., Harlow, E., and Helin, K. (1993). Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol. Cell. Biol. 13, 7267-7277.
17. Field, S.J., Tsai, F.-Y., Kuo, F., Zubiaga, A.M., Kaelin, W.G., Jr., Livingston, D.M., Orkin, S.H., and Greenberg, M.E. (1996). E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549-561.
18. Ge, H., and Roeder, R.G. (1994). Purification, cloning, and characterization of a human coactivator, PC4, that mediates transcriptional activation of class II genes. Cell 78, 513-523.
19. Helin, K., Harlow, E., and Fattaey, A.R. (1993a). Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13, 6501-6508.
20. Helin, K., Wu, C., Fattaey, A., Lees, J., Dynlacht, B., Ngwu, C., and Harlow, E. (1993b). Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative transactivation. Genes Dev. 7, 1850-1861.
21. Hiebert, S.W. (1993). Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol. Cell. Biol. 13, 3384-3391.
22. Holstege, F.C.P., Tantin, D., Carey, M., van der Vliet, P.C., and Timmers, H.T.M. (1995). The requirement for the basal transcription factor IIE is determined by the helical stability of promoter DNA. EMBO J. 14, 810-819.
23. Kadonaga, J.T. (1990). Assembly and disassembly of the Drosophila RNA polymerase II complex during transcription. J. Biol. Chem. 265, 2624-2631.
24. Kim, J.L., and Burley, S.K. (1994). 1.9 Å resolution refined structure of TBP recognizing the minor groove of TATAAAAG. Nat. Struct. Biol. 1, 638-653.
25. Kobayashi, N., Boyer, T.G., and Berk, A.J. (1995). A class of activation domains interacts directly with TFIIA and stimulates TFIIA-TFIID-promoter complex assembly. Mol. Cell. Biol. 15, 6465-6473.
26. Kraus, W.L., and Kadonaga, J.T. (1998). p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes Dev. 12, 331-34 2.
27. Larminie, C.G.G., Cairns, C.A., Mital, R., Martin, K., Kouzarides, T., Jackson, S.P., and White, R.J. (1997). Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein. EMBO J. 16, 2061-2071.
28. Leone, G., DeGregori, J., Yan, Z., Jakoi, L., Ishida, S., Williams, R.S., and Nevins, J.R. (1998). E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev. 12, 2120-2130.
29. LeRoy, G., Drapkin, R., Weis, L., and Reinberg, D. (1998). Immunoaffinity purification of the human multisubunit transcription factor IIH. J. Biol. Chem. 273, 7134-7140.
30. Lieberman, P.M., and Berk, A.J. (1994). A mechanism for TAFs in transcriptional activation: Activation domain enhancement of TFIID-TFIIA-promoter DNA complex formation. Genes Dev. 8, 995-1006.
31. Ludlow, J.W., Shon, J., Pipas, J.M., Livingston, D.M., and DeCaprio, J.A. (1990). The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 60, 387-396.
32. Luo, R.X., Postigo, A.A., and Dean, D.C. (1998). Rb interacts with histone deacetylase to repress transcription. Cell 92, 463-473.
33. Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Levillain, J.P., Troalen, F., Trouche, D., and Harel-Bellan, A. (1998). Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601-605.
34. Maldonado, E., Drapkin, R., and Reinberg, D. (1996). Purification of human RNA polymerase II and general transcription factors. Methods Enzymol. 274, 72-100.
35. Maldonado, E., Ha, I., Cortes, P., Weis, L., and Reinberg, D. (1990). Factors involved in specific transcription by mammalian RNA polymerase II: Role of transcription factors IIA, IID, and IIB during formation of a transcription-competent complex. Mol. Cell. Biol. 10, 6335-6347.
36. Marshak, D.R., Kadonaga, J.T., Burgess, R.R., Knuth, M.W., Brennan, W.A., and Lin, S.-H. (1996). Strategies for Protein Purification and Characterization: A Laboratory Course Manual (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press).
37. Meisterernst, M., Roy, A.L., Hsiao, M.K., and Roeder, R.G. (1991). Activation of class II gene transcription by regulatory factors is potentiated by a novel activity. Cell 66, 981-993.
38. Mulligan, G., and Jacks, T. (1998). The retinoblastoma gene family: Cousins with overlapping interests. Trends Genet. 14, 223-229.
39. Olave, I., Reinberg, D., and Vales, L.D. (1998). The mammalian transcriptional repressor RBP (CBF1) targets TFIID and TFIIA to prevent activated transcription. Genes Dev. 12, 1621-1637.
40. Ozer, J., Moore, P.A., Bolden, A.H., Lee, A., Rosen, C.A., and LieberMan, P.M. (1994). Molecular cloning of the small (γ) subunit of human TFIIA reveals functions critical for activated transcription. Genes Dev. 8, 2324-2335.
41. Parvin, J.D., Timmers, H.T.M., and Sharp, P.A. (1992). Promoter specificity of basal transcription factors. Cell 68, 1135-1144.
42. Peterson, M.G., Inostroza, J., Maxon, M.E., Flores, O., Admon, A., Reinberg, D., and Tjian, R. (1991). Structure and functional properties of human general transcription factor IIE. Nature 354, 369-373.
43. Pierce, A.M., Fisher, S.M., Conti, C.J., and Johnson, D.G. (1998). Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene 16, 1267-1276.
44. Sanchez, I., and Dynlacht, B.D. (1996). Transcriptional control of the cell cycle. Curr. Opin. Cell Biol. 8, 318-324.
45. Sawadogo, M., and Roeder, R.G. (1985). Factors involved in specific transcription by human RNA polymerase II: Analysis by a rapid and quantitative in vitro assay. Proc. Natl. Acad. Sci. USA 82, 4394-4398.
46. Sellers, W.R., Rodgers, J.W., and Kaelin, W.G., Jr. (1995). A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA 92, 11544-11548.
47. ∥250. Proc. Natl. Acad. Sci. USA 92, 3115-3119.
48. Sherr, C.J. (1996). Cancer cell cycles. Science 274, 1672-1677.
49. Shykind, B.M., Kim, J., Stewart, L., Champoux, J.J., and Sharp, P.A. (1997). Topoisomerase I enhances TFIID-TFIIA complex assembly during activation of transcription. Genes Dev. 11, 397-407.
50. Singh, P., Wong, S.H., and Hong, W. (1994). Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13, 3329-3338.
51. Tan, S., Aso, T., Conaway, R.C., and Conaway, J.W. (1994). Roles for both the RAP30 and RAP74 subunits of transcription factor IIF in transcription initiation and elongation by RNA polymerase II. J. Biol. Chem. 269, 25684-25691.
52. Thompson, N.E., Aronson, D.B., and Burgess, R.R. (1990). Purification of eukaryotic RNA polymerase II by immunoaffinity chromatography: Elution of active enzyme with protein stabilizing agents from a polyol-responsive monoclonal antibody. J. Biol. Chem. 265, 7069-7077.
53. Van Dyke, M.W., Roeder, R.G., and Sawadogo, M. (1988). Physical analysis of transcription preinitiation complex assembly on a class II gene promoter. Science 241, 1335-1338.
54. Verrijzer, C.P., Chen, J.-L., Yokomori, K., and Tjian, R. (1995). Binding of TAFs to core elements directs promoter selectivity by RNA polymerase II. Cell 81, 1115-1125.
55. Verrijzer, C.P., and Tjian, R. (1996). TAFs mediate transcriptional activation and promoter selectivity. Trends Biochem. Sci. 21, 338-342.
56. Voit, R., Schafer, K., and Grummt, I. (1997). Mechanism of repression of RNA polymerase I transcription by the retinoblastoma protein. Mol. Cell. Biol. 17, 4230-4237.
57. Weinberg, R.A. (1995). The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
58. Weintraub, S.J., Chow, K.N.B., Luo, R.X., Zhang, S.H., He, S., and Dean, D.C. (1995). Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375, 812-815.
59. Xu, G., Livingston, D.M., and Krek, W. (1995). Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. USA 92, 1357-1361.
60. Yamasaki, L., Bronson, R., Williams, B.O., Dyson, N.J., Harlow, E., and Jacks, T. (1998). Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-) mice. Nat. Genet. 18, 360-364.
61. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E., and Dyson, N.J. (1996). Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537-548.
62. Zhou, Q., Lieberman, P.M., Boyer, T.G., and Berk, A.J. (1992). Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter. Genes Dev. 6, 1964-1974.